Novo Nordisk Aims to Launch Oral Wegovy in China to Expand Obesity Treatment Market
Novo Nordisk plans to seek regulatory approval for its oral Wegovy in China soon, intensifying competition with Eli Lilly in the country’s growing obesity drug sector.

